fbpx

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

HIPEC Increased Survival in Gastric Cancer With Peritoneal Metastasis

Data shared at ASCO’s Gastrointestinal Cancers Symposium also included research that found hyperthermic intraperitoneal chemotherapy (HIPEC), which delivers chemotherapy directly to cancer cells in the abdomen, increases survival for gastric cancer patients with peritoneal metastasis.

Read Source

 

Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFODONATE
X